Cambridge, United Kingdom
Syngene is a UK-based company founded in 1985, specializing in providing instruments, software, and systems for molecular biologists in genomic and proteomic studies. Their expertise lies in offering optical imaging solutions tailored to the unique needs of researchers and laboratories in the biological sciences.
With a comprehensive product range spanning from entry-level kits to advanced computer-controlled automatic analyzers for fluorescence, chemiluminescence, and proteomics workstations, Syngene caters to a broad spectrum of needs in the industry.
Their offerings include gel documentation (gel doc) and image analysis systems for DNA and protein gels, chemiluminescence and fluorescence systems for Western blots and probes, as well as proteomics hardware and software for 2D gel electrophoresis (2DGE).
The company is strategically headquartered in Cambridge, UK, which is a thriving scientific hub, and maintains a central US subsidiary in Frederick, USA. Syngene operates through a global network of highly-trained distributors, ensuring strong product support, with all distributors employing imaging specialists.
Given their specialization, strategic locations, and global reach, Syngene presents an intriguing opportunity for potential investment in the realms of manufacturing and pharmaceutical industries.
